BIIO (Bionovate Technologies) Total Operating Expense: $0.05 Mil (TTM As of Sep. 2021)


What is Bionovate Technologies Total Operating Expense?

Bionovate Technologies BIIO Total Operating Expense is $0.05 Mil as of Sep. 2021.

Bionovate Technologies's Total Operating Expense for the three months ended in Sep. 2021 was $0.01 Mil. Bionovate Technologies's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2021 was $0.05 Mil.

Bionovate Technologies Total Operating Expense Related Terms

Bionovate Technologies Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies Total Operating Expense Chart

Bionovate Technologies Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only 0.09 0.12 0.06 0.03 0.05

Bionovate Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.02 0.02 0.00 0.01

Bionovate Technologies Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.05 Mil mean?
Bionovate Technologies (BIIO) has a Total Operating Expense of $0.05 Mil as of Sep. 2021. Total operating expense is the primary recurring expense associated with central operations. View historical data on Bionovate Technologies and its competitors.
Is Bionovate Technologies' Total Operating Expense too high?
Bionovate Technologies' current Total Operating Expense is $0.05 Mil.
How does Bionovate Technologies' Total Operating Expense compare to ABT and MDT?
Bionovate Technologies' Total Operating Expense of $0.05 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Bionovate Technologies and its competitors. Bionovate Technologies's current Total Operating Expense is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionovate Technologies stock overvalued right now?
Bionovate Technologies (BIIO) has a current Total Operating Expense of $0.05 Mil. The current Total Operating Expense is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current Total Operating Expense is $0.05 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Address 950 W Bannock Street, Boise, ID, USA, 83702
Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.